Worldwide: Patent

World Law Group's Intellectual Property Group explored this question in a discussion moderated by Stephanie Consonni de Schryver from TozziniFreire in Brazil, where lawyers from multiple jurisdictions shared how IP is influencing deal value, diligence, and risk allocation in practice.

In California, an employer’s invention-assignment agreement often looks like it gives the company ownership of every idea an employee touches. For engineers at high-growth technology companies...

InMode accused BTL of infringing a patent related to vaginal remodeling technology and methods. Following a stay pending a decision on the institution of an inter partes review...

This comprehensive legal update examines recent developments in intellectual property law, including a landmark Supreme Court decision on ISP liability for copyright infringement, new USPTO guidance expanding design patent protection for virtual interfaces, and significant international trademark and privacy law changes across multiple jurisdictions.

On April 6, 2026, the Artemis II crew swung around the far side of the moon, shattered the Apollo 13 distance record by traveling nearly 253,000 miles from home, and enjoyed front-row...

In the district court, Teva asserted several patents, including patents to anti-CGRP antibodies and methods of treatment. Teva asserted a number of its patents against Lilly in district court. In response, Lilly challenged all of the patents in IPRs, arguing that anti-CGRP antibodies were well known—the prior art was “replete with exemplary disclosures.” The board agreed with Lilly on the antibody patents and found them unpatentable, but upheld the method of treatment claims.

The USPTO has issued a notice regarding a new pilot program. The notice indicates that USPTO will select certain national stage patent applications for participation...

The US Patent & Trademark Office has introduced a new pilot program that fundamentally changes how certain PCT-based patent applications will be examined in the United States. This program creates mandatory response windows and new strategic considerations for applicants entering the US national phase. Patent applicants must now carefully evaluate their filing strategies to avoid potential pitfalls that could affect patent term adjustment or lead to abandonment.

The U.S. Court of Appeals for the Federal Circuit recently affirmed the Patent Trial and Appeal Board's (Board) rejection of a patent application directed to an "information exchange apparatus...